Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Posted by THTX

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Feb 11, 2023 4:29pm

86 Views

Post# 35281628

RE:Posted by THTX

They shure like the celebrating overthere... we the shareholders are celebrating the third month the stock prints 90 cents on the statement.... ESG, Martin Lutherking, Women day, LGBTQ embracing day... Best work place in Canada, Best friend for ever day... it's a joke.

<< Previous

Bullboard Posts

Next >>

First Nations contributions attract investor interest